Literature DB >> 7914880

Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse.

P Sempé1, M F Richard, J F Bach, C Boitard.   

Abstract

The NOD mouse, which shows many features of human IDDM, is extensively used to evaluate the role of T lymphocytes in the pathogenesis of autoimmune diabetes. The development of diabetes in this model appears to be controlled by a finely tuned immunoregulatory balance between autoaggressive T cells and regulatory immune phenomena, the disruption of which may result in destruction of insulin-secreting cells. The absolute requirement of sublethal irradiation to permit transfer of the disease to non-diabetic adult syngeneic mice provides indirect evidence for the presence of regulatory T cells in non-diabetic NOD mice. We have previously reported that the reconstitution of irradiated recipients by CD4+ T cells from nondiabetic female NOD mice blocks the transfer of diabetes by spleen cells from diabetic donors. We now report evidence that anti-CD4 monoclonal antibodies can substitute for irradiation in rendering adult NOD male mice susceptible to diabetes transfer by diabetogenic spleen cells. Efficient diabetes transfer can be achieved in non-irradiated adult NOD recipients provided they are thymectomized and CD4+ T-cell depleted prior to the transfer. The role of thymectomy is to limit T cell regeneration after anti-T cell monoclonal antibody challenge. Our data confirm that regulatory CD4+ T-cells, which efficiently counterbalance diabetogenic cells, are present in adult NOD male animals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914880     DOI: 10.1007/bf00408468

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  Pancreatic islet-specific T-cell clones from nonobese diabetic mice.

Authors:  K Haskins; M Portas; B Bergman; K Lafferty; B Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.

Authors:  A Pacheco-Silva; M G Bastos; R A Muggia; O Pankewycz; J Nichols; J R Murphy; T B Strom; V E Rubin-Kelley
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

3.  Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.

Authors:  O Pankewycz; T B Strom; V E Rubin-Kelley
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

4.  Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.

Authors:  D Zipris; A H Lazarus; A R Crow; M Hadzija; T L Delovitch
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

5.  Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice.

Authors:  P Sempé; P Bédossa; M F Richard; M C Villà; J F Bach; C Boitard
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

6.  Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.

Authors:  V E Kelley; G N Gaulton; M Hattori; H Ikegami; G Eisenbarth; T B Strom
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

7.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

8.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

Authors:  M J Rapoport; A Jaramillo; D Zipris; A H Lazarus; D V Serreze; E H Leiter; P Cyopick; J S Danska; T L Delovitch
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

9.  T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice.

Authors:  C Boitard; R Yasunami; M Dardenne; J F Bach
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential.

Authors:  D Fowell; D Mason
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  3 in total

1.  Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.

Authors:  Sylvaine You; Géraldine Slehoffer; Samia Barriot; Jean-François Bach; Lucienne Chatenoud
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

2.  Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

Authors:  W W Hancock; M Polanski; J Zhang; N Blogg; H L Weiner
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

3.  Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes.

Authors:  J Salaün; N Simmenauer; P Belo; A Coutinho; N M Le Douarin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.